|
|
|
Volumn 7 Suppl 3, Issue , 2001, Pages
|
|
Angiogenesis inhibition in solid tumors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ENDOTHELIAL CELL GROWTH FACTOR;
GROWTH FACTOR RECEPTOR;
INDOLE DERIVATIVE;
LYMPHOKINE;
MONOCLONAL ANTIBODY;
PROTEIN TYROSINE KINASE;
PYRROLE DERIVATIVE;
SEMAXANIB;
VASCULOTROPIN;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
DRUG ANTAGONISM;
HUMAN;
KAPOSI SARCOMA;
NEOPLASM;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
ENDOTHELIAL GROWTH FACTORS;
HUMANS;
INDOLES;
LYMPHOKINES;
NEOPLASMS;
PYRROLES;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTORS, GROWTH FACTOR;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
SARCOMA, KAPOSI;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0035525207
PISSN: 15289117
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (56)
|
|
References (63)
|
